THC - NYSE

Tenet Healthcare Corporation

THC·NYSE

$164.84

+0.76%

HealthcareMedical - Care Facilities

Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb-salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, and telemedicine access services. In addition, it operates ambulatory surgery and urgent care centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals; and offers healthcare business process services in the areas of hospital and physician revenue cycle management, patient communications and engagement support, and value-based care solutions to hospitals, health systems, physician practices, employers, and other customers. As of February 09, 2022, the company operated 60 hospitals; and approximately 550 other healthcare facilities, including surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and other care sites and clinics. Tenet Healthcare Corporation was incorporated in 1975 and is headquartered in Dallas, Texas.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$14.20B

EPS15.6100

P/E Ratio10.56

Earnings Date07/28/2026

29.68B

Assets

3Y+9.0%

5Y+9.0%

10Y+20.0%

20.70B

Total Liabilities

3Y-8.0%

5Y-15.0%

10Y-2.0%

8.97B

Total Equity

3Y+95.0%

5Y+211.0%

10Y+158.0%

Tenet Healthcare Corporation Funding & Solvency Profile

THC · NYSE

Current Assets

Cash & Cash Equivalents2.88B

Net Receivables2.56B

Inventory348.00M

Other Current Assets2.05B

Total Current Assets8 B

Non-Current Assets

Property, Plant & Equipment6.32B

Goodwill & Intangible Assets12.55B

Long-Term Investments2.88B

Other Non-Current Assets84.00M

Total Non-Current Assets9 B

Total Assets

29.68B

Financial Health Analysis

Current Ratio

1.76x

Strong liquidity. The company has adequate resources to meet short-term liabilities.

Debt-to-Equity Ratio

2.31x

High financial leverage. Heavy reliance on debt may indicate increased financial risk and potential solvency concerns.

Working Capital

3 B

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

26% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Tenet Healthcare Corporation Balance Sheet

THC • NYSE

Tenet Healthcare Corporation Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	2.9B	3B	1.2B	858M	2.4B	2.4B	262M	411M	611M	716M	356M	193M	113M	364M	113M	405M	690M	507M	572M	784M
Short-Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1M	13M	16M	20M	39M
Cash & Short-Term Investments	2.9B	3B	1.2B	858M	2.4B	2.4B	262M	411M	611M	716M	356M	193M	113M	364M	113M	406M	703M	523M	592M	823M
Net Receivables	2.6B	3.1B	3.4B	3.5B	3.3B	3.4B	3.3B	3.1B	3B	3.4B	3.1B	2.4B	1.9B	1.3B	1.3B	1.3B	1.2B	1.5B	1.6B	1.7B
Accounts Receivables	2.6B	3.1B	3.4B	3.5B	3.3B	3.4B	3.3B	3.1B	3B	3.4B	3.1B	2.4B	1.9B	1.3B	1.3B	1.1B	1.2B	1.3B	1.4B	1.4B
Other Receivables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	165M	153M	126M	110M	164M	314M
Inventory	348M	346M	411M	405M	384M	368M	310M	305M	289M	326M	309M	276M	262M	153M	161M	156M	153M	161M	183M	184M
Prepaids	0.0	368M	391M	400M	252M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73M	70M	70M	84M	91M	103M
Other Current Assets	2.1B	895M	1.7B	856M	769M	982M	1.2B	827M	1.6B	783M	1.4B	1.1B	1.4B	828M	725M	394M	349M	481M	138M	188M
Total Current Assets	7.8B	7.7B	7.2B	6B	7.1B	7.1B	5.1B	4.6B	5.6B	5.3B	5.2B	4.7B	3.7B	2.7B	2.4B	2.3B	2.5B	2.7B	2.6B	3B
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	6.3B	7.1B	7.3B	7.6B	7.4B	7.8B	7.8B	7B	7B	8.1B	7.9B	7.7B	7.7B	4.3B	4.4B	4.3B	4.3B	4.3B	4.6B	4.3B
Goodwill	11.2B	10.7B	10.3B	10.1B	9.3B	8.8B	7.3B	7.3B	7B	7.4B	7B	3.9B	3B	916M	736M	652M	607M	609M	607M	601M
Intangible Assets	1.3B	1.4B	1.4B	1.4B	1.5B	1.6B	1.6B	1.7B	1.8B	1.8B	1.7B	1.3B	1.2B	650M	489M	442M	379M	323M	293M	231M
Goodwill & Intangible Assets	12.5B	12.1B	11.7B	11.5B	10.8B	10.4B	8.9B	9B	8.8B	9.3B	8.6B	5.2B	4.2B	1.6B	1.2B	1.1B	986M	932M	900M	832M
Long-Term Investments	2.9B	1.8B	1.9B	1.8B	2B	1.2B	1.2B	1.2B	1.3B	984M	1.2B	133M	118M	162M	45M	53M	57M	242M	288M	0.0
Tax Assets	0.0	80M	77M	19M	65M	325M	169M	312M	455M	871M	776M	116M	90M	342M	374M	627M	108M	82M	87M	0.0
Other Non-Current Assets	84M	194M	180M	192M	224M	239M	264M	229M	263M	266M	0.0	447M	486M	0.0	184M	181M	125M	31M	35M	383M
Total Non-Current Assets	21.8B	21.3B	21.1B	21.2B	20.5B	20B	18.3B	17.8B	17.8B	19.4B	18.5B	13.4B	12.4B	6.4B	6.1B	6.2B	5.5B	5.5B	5.8B	5.5B
Total Assets	29.7B	28.9B	28.3B	27.2B	27.6B	27.1B	23.4B	22.4B	23.4B	24.7B	23.7B	18.1B	16.1B	9B	8.5B	8.5B	8B	8.2B	8.4B	8.5B
LIABILITIES
CURRENT LIABILITIES
Total Payables	1.4B	1.3B	1.4B	1.5B	1.3B	1.2B	1.2B	1.2B	1.2B	1.3B	1.4B	1.2B	1.1B	722M	760M	720M	739M	686M	780M	775M
Accounts Payable	1.4B	1.3B	1.4B	1.5B	1.3B	1.2B	1.2B	1.1B	1.1B	1.2B	1.4B	1.1B	1.1B	722M	760M	720M	739M	686M	780M	775M
Other Payables	0.0	18M	23M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Accrued Expenses	1.2B	149M	200M	213M	203M	248M	245M	240M	256M	210M	499M	239M	198M	125M	176M	123M	573M	293M	245M	591M
Short Term Debt	79M	296M	120M	145M	135M	145M	171M	182M	146M	191M	127M	112M	153M	94M	66M	67M	2M	2M	1M	22M
Tax Payables	0.0	18M	23M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Revenue	0.0	0.0	0.0	110M	959M	659M	61M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Current Liabilities	1.8B	2.6B	3B	2.5B	2.5B	2.6B	2.5B	2.2B	2.8B	2.3B	2.3B	2B	1.7B	822M	813M	815M	469M	968M	1B	537M
Total Current Liabilities	4.5B	4.3B	4.8B	4.5B	5.1B	4.8B	4.2B	3.9B	4.3B	4B	4.3B	3.6B	2.9B	1.8B	1.8B	1.7B	1.8B	1.9B	2B	1.9B
NON-CURRENT LIABILITIES
Long Term Debt	13.1B	12.7B	14.9B	14.9B	15.5B	15.6B	14.6B	14.6B	14.8B	15.1B	14.4B	11.5B	10.7B	5.2B	4.3B	4B	4.3B	4.8B	4.8B	4.8B
Deferred Revenue (Non-Current)	0.0	13M	0.0	13M	15M	918M	18M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Tax Liabilities (Non-Current)	0.0	227M	326M	217M	36M	29M	27M	36M	36M	279M	37M	0.0	0.0	0.0	0.0	0.0	148M	101M	119M	107M
Other Non-Current Liabilities	3.1B	1.8B	2.8B	2.9B	2.7B	2.8B	2.6B	1.8B	1.8B	1.8B	1.7B	1.7B	1.4B	889M	845M	959M	1.1B	1.2B	1.4B	1.5B
Total Non-Current Liabilities	16.2B	16.1B	18B	18.1B	18.2B	19.4B	17.2B	16.4B	16.6B	17.2B	16.2B	13.4B	12.1B	6B	5.1B	5B	5.5B	6.1B	6.3B	6.4B
Capital Lease Obligations	0.0	1.3B	0.0	0.0	0.0	0.0	1B	425M	431M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	20.7B	20.4B	22.8B	22.5B	23.3B	24.2B	21.4B	20.3B	21B	21.2B	20.5B	17B	15B	7.8B	7B	6.7B	7.3B	8.1B	8.3B	8.3B
SHAREHOLDERS' EQUITY
Treasury Stock	-4.9B	-3.5B	-2.9B	-2.7B	-2.4B	-2.4B	-2.4B	-2.4B	-2.4B	-2.4B	-2.4B	-2.4B	-2.4B	-2B	-1.9B	-1.5B	-1.5B	-1.5B	-1.5B	-1.5B
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	334M	334M	334M	0.0	0.0	0.0
Common Stock	8M	8M	8M	8M	8M	7M	7M	7M	7M	7M	7M	7M	7M	7M	27M	27M	27M	26M	26M	26M
Additional Paid-In Capital	4.9B	4.9B	4.8B	4.8B	4.9B	4.8B	4.8B	4.7B	4.9B	4.8B	4.8B	4.6B	4.6B	4.5B	4.4B	4.4B	4.5B	4.4B	4.4B	4.4B
Retained Earnings	4.4B	3B	-192M	-803M	-1.2B	-2.1B	-2.5B	-2.2B	-2.4B	-1.7B	-1.6B	-1.4B	-1.4B	-1.3B	-1.4B	-1.5B	-2.7B	-2.9B	-2.9B	-2.6B
Accumulated Other Comprehensive Income/Loss	-181M	-180M	-181M	-181M	-233M	-281M	-257M	-223M	-204M	-258M	-164M	-182M	-24M	-68M	-52M	-43M	-32M	-37M	-28M	-45M
Total Stockholders' Equity	4.2B	4.2B	1.6B	1.1B	1B	28M	-371M	-119M	-147M	417M	691M	651M	755M	1.1B	1.4B	1.8B	646M	103M	54M	264M
Total Equity	9B	8.5B	5.5B	4.6B	4.3B	2.9B	2B	2.1B	2.4B	3.5B	3.2B	1.2B	1.1B	1.2B	1.5B	1.8B	697M	103M	54M	264M
Minority Interest	4.8B	4.4B	3.9B	3.5B	3.2B	2.9B	2.4B	2.2B	2.6B	3.1B	2.5B	535M	370M	91M	85M	53M	51M	0.0	0.0	0.0
SUMMARY
Total Liabilities & Equity	29.7B	28.9B	28.3B	27.2B	27.6B	27.1B	23.4B	22.4B	23.4B	24.7B	23.7B	18.1B	16.1B	9B	8.5B	8.5B	8B	8.2B	8.4B	8.5B
Total Investments	2.9B	1.8B	1.9B	1.8B	2B	1.2B	1.2B	1.2B	1.3B	984M	1.2B	133M	118M	162M	45M	54M	70M	258M	308M	39M
Total Debt	13.2B	14.3B	15B	15.1B	15.6B	15.7B	14.8B	14.8B	14.9B	15.3B	14.5B	11.6B	10.8B	5.3B	4.4B	4.1B	4.3B	4.8B	4.8B	4.8B
Net Debt	10.3B	11.3B	13.8B	14.2B	13.3B	13.3B	14.5B	14.4B	14.3B	14.5B	14.2B	11.4B	10.7B	4.9B	4.2B	3.7B	3.6B	4.3B	4.2B	4B
Shares Outstanding	87,885,145	87,885,145	87,885,145	87,885,145	87,885,145	87,885,145	87,885,145	87,885,145	87,885,145	87,885,145	87,885,145	87,885,145	87,885,145	87,885,145	87,885,145	87,885,145	87,885,145	87,885,145	87,885,145	87,885,145

SEC Filings

THC - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 29, 2026	May 27, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	April 30, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 30, 2026	April 30, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 16, 2026	May 27, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 10, 2026	April 09, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 30, 2026	March 25, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 17, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 11, 2026	February 11, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 02, 2026	January 27, 2026	2026	View Filing
8-K 8-K 2025 N/A	November 24, 2025	November 21, 2025	2025	View Filing

Showing 1 to 10 of 665 filings

Related Guides

Blog Categories

Continue your THC research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.